Relapsed and/or Refractory Acute Myeloid Leukemia
1 clinical trials · Condition
◉ Watch Relapsed and/or Refractory Acute Myeloid Leukemia
| Record | Firm | Date |
|---|---|---|
| Anti-CD33 CAR-T Cells for the Treatment of Relapsed/Refractory CD33+ Acute Myeloid Leukemia (NCT05445765) | iCell Gene Therapeutics | 2022-07-01 |
Track Relapsed and/or Refractory Acute Myeloid Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.